Kaiseraugst (Switzerland), Maastricht (Netherlands), April 16, 2024
dsm-firmenich today announces that it has repurchased 500,000 ordinary shares in the period from April 8, 2024 up to and including April 12, 2024 at an average price of €103.29. This is in accordance with the on-market share repurchase program announced on April 8, 2024, covering commitments under the Group’s share-based compensation plans. This repurchase concludes the program to repurchase 500,000 shares for a total consideration of €51.6 million.
For more detailed information, see ‘Daily transaction details On-Market Share Repurchase Program announced April 8, 2024’.
As announced on April 8, 2024, the on-market share repurchase program is followed by a repurchase of 1,000,000 shares by means of an equity forward transaction. The forward transaction is expected to be entered into in April 2024, and dsm-firmenich expects to take delivery of the shares in 2025.
For more information, please contact:
dsm-firmenich media enquiries: media@dsm-firmenich.com
dsm-firmenich investor relations enquiries: investors@dsm-firmenich.com
About dsm-firmenich:
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life every day, everywhere, for billions of people.
